|
| Epithelial tumours |
|
| Malignant | Benign |
|
| (i) Acinic cell carcinoma | (i) Pleomorphic adenoma (PA) |
| (ii) Mucoepidermoid carcinoma (MEC) | (a) Metastasizing pleomorphic adenoma |
| (iii) Adenoid cystic carcinoma (ACC) | (ii) Myoepithelioma |
| (iv) Polymorphous adenocarcinoma (PAC) (before 2017: Polymorphous low-grade adenocarcinoma – PLGA) | (iii) Basal cell adenoma |
| (v) Epithelial-myoepithelial carcinoma (EMC) | (iv) Warthin’s tumour |
| (vi) Clear cell carcinoma | (v) Oncocytoma |
| (vii) Basal cell adenocarcinoma | (vi) Canalicular adenoma |
| (viii) Sebaceous carcinoma | (vii) Lymphadenoma |
| (ix) Intraductal carcinoma | (a) Sebaceous lymphadenoma |
| (a) Low-grade cribriform cystadenocarcinoma | (b) Nonsebaceous lymphadenoma |
| (b) Salivary duct carcinoma | (c) Sebaceous lymph adenocarcinoma |
| (c) Salivary duct carcinoma, not otherwise specified | (viii) Ductal papilloma |
| (x) Oncocytic carcinoma | (a) Inverted ductal papilloma |
| (xi) Adenocarcinoma, not otherwise specified (NOS) | (b) Intraductal papilloma |
| (a) Cystadenocarcinoma | (c) Sialadenoma papilliferum |
| (b) Mucinous adenocarcinoma | (ix) Cystadenoma |
| (xii) Myoepithelial carcinoma | |
| (xiii) Carcinoma ex pleomorphic adenoma (CXPA) | |
| (xiv) Secretory carcinoma | |
| (xv) Carcinosarcoma | |
| (xvi) Squamous cell carcinoma | |
| (xvii) Large cell carcinoma | |
| (xviii) Lymphoepithelial carcinoma | |
| (xix) Sialoblastoma | |
|
| Other epithelial lesions |
|
| (i) Intercalated duct lesions |
| (a) Intercalated duct adenoma |
| (b) Intercalated duct hyperplasia (IDH) |
| (ii) Nodular oncocytic hyperplasia |
| (iii) Lymphoepithelial lesions |
|
| Soft tissue tumours |
|
| (i) Haemangioma |
| (ii) Lipoma |
| (iii) Nodular fasciitis |
|
| Haematolymphoid tumours |
|
| (i) Hodgkin lymphoma |
| (ii) Diffuse large B-cell lymphoma |
| (iii) Extranodal marginal zone B-cell lymphoma |
|
| Secondary tumours |
|
| (i) Tumours which have metastasized to the salivary gland from another location |
|
